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ELSEVIER
Partial Trisomy 9  in a Patient with Polycythemia Vera
Trisomy 9 as sole abnormality has been described in sev­
eral hematologic disorders, with acute non lymphocytic 
leukemia (ANLL) and polycthemia vera (PV) having the 
largest num ber of cases [1]. Trisomy 9 in PV can be com­
plete or partial and is often associated with trisomy lq  [2, 
3]. Other abnormalities in PV include trisomies for 8 and 
lq , 13q— and 2 0 q -  [2-6],
We w ish to present a patient with polycythemia vexa, 
who had an abnormal clone in her bone marrow with a 
partial trisomy 9p, as a result of an unbalanced transloca­
tion, t(2;9). The patient, an 82-year old Caucasian female, 
presented w ith  a two-month history of parasthesia of the 
left side of the body, without pruritus or increased bleed­
ing tendency. At physical examination the spleen was not 
enlarged.
Laboratory findings included ESR 1 mm (normal <10), 
hemoglobin 11 mmol/L (normal 7.8 to 10.2), hematocrit
0.54 L/L (normal 0.37 to 0.48), mean corpuscular volume 
(MCV) 75.2 fl (normal 82 to 98), erythrocytes 7.2 X 1 0 6/( jl1 
(normal 4 to 5.5), leukocytes 15.0 X 10°/ml (normal 4.0 to 
10.0), and thrombocytes 766 X 10fi/ml (normal 150 to 350). 
The differential showed 79% neutrophils, 18% lympho­
cytes, and 3% monocytes.
A biochemical profile revealed a lactic dehydrogenase 
of 366 U/L (normal <290), uric acid 0.32 (normal <0.36), 
and was otherwise normal. Arterial 0 2 saturation was 95% 
(normal 95 to 98).
Serum level of iron was 2.5 jxmol/L (normal 14 to 32), 
ferritin 12.2 |xg/L (7 to 283), and vitamin B12 812 pmol/L 
(normal 130 to 550). Leukocyte alkaline phosphatase ac­
tivity was 159 (normal 20 to 90). On ultrasound the spleen 
was not enlarged. Bone marrow examination revealed ac­
tive normoblastic and megaloblastic erythropoiesis, active 
myelopoiesis, and increased megakaryopoiesis with hy­
pergranularity of the megakaryocytes. On histology nu­
merous enlarged and hyperlobulated megakaryocytes 
were present without evident fibrosis. A myeloprolifera­
tive syndrome was diagnosed, compatible with poly­
cythemia vera. The symptoms subsided after treatment 
w ith a low dose of acetylsalicylic acid (80 mg per day) and 
repeated phlebotomies.
Cytogenetic analysis was performed on 24 hours cul­
tured bone marrow without mitogen. The karyotype, 
based on conventional cytogenetics, was 46,XX,add(2) 
(p25)[24]/46,XX[9]. The abnormal chromosome 2 is shown 
in Figure 1.
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Fluorescence in situ hybridization (FISH), using ICRF 
YAC y900B0992 and CEPH YAC 937c8 (kindly provided 
by J. Wagstaff, Children’s Hospital, Boston), demonstrated 
that the extra material on the tip of chromosome 2 was de­
rived from the short arm of chromosome 9 (Fig. 2.) The 
karyotype of the abnormal cell clone therefore is 46,XX, 
add(2)(p25),ish der(2)t(2;9)(p25;p?).
During the course of PV the percentage of patients with 
chromosomal abnormalities in the bone marrow increases, 
partly as a result of myelosuppressive cytostatic treatment
[2]. Although patients with chromosomally abnormal 
clones at the time of diagnosis of PV may have a poor 
prognosis [4], the significance of trisomy 9 is not clear. 
Mostly no consistent relationship between the presence of 
trisomy 9 and the course of PV has been established [2,4, 
5]; in one report the presence of trisomy 9 was even asso­
ciated with a long duration of the disease [6].
Recently, Amiel et al. [6] demonstrated that FISH is a 
more sensitive method for detecting trisomy 9 dian con­
ventional cytogenetics, offering the possibility to examine 
a large number of cells and thus detecting cells with tri­
somy 9 that would otherwise not have been found. Our 
patient had a structural abnormality resulting in a partial 
trisomy 9p, possibly in combination with a small mono­
somy 2p, that could only be identified by FISH.
Figure 1 Partial G-banded karyotype, showing both chrom o­
somes 2. The abnormal chromosome is indicated by an arrow.
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Figure 2 Metaphase after fluorescence in situ hybridization 
with YACS located on the short arm of chromosome 9, showing 
signals on both normal chromosomes 9, indicated by asterisks, 
and on the der(2), indicated by an arrow,
The detection of more patients with partial trisomy 9, 
made possible by FISH, might help to delineate the critical 
region on 9p that contains the gene(s) involved in myelo­
proliferative diseases.
We thank A. Geurts van Kessel for advice and support and Mar­
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